DealTubulis GmbH, a Munich-based clinical-stage ADC biotech, was acquired for $5.0 billion by Gilead Sciences, Inc..
More on STAT+ →
M&A
04/11/2026
Ambrosia Biosciences, a Boulder, CO-based oral GLP-1 therapeutics...
TeiaCare, a Milan-based healthcare technology company, raised €7 million...
Ambient Clinical Analytics, a Rochester, MN-based real-time clinical...
ReAlta Life Sciences, a Norfolk, VA-based clinical-stage biotech, raised...
Stipple Bio, a Cambridge, MA-based biotech therapeutics company, raised...
Sidewinder Therapeutics, a San Diego-based oncology biotech developing...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
